Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 27 (September 20), 2005: pp. 6793-6794
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.08.118

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokote, T.
Right arrow Articles by Hanafusa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokote, T.
Right arrow Articles by Hanafusa, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

DIAGNOSIS IN ONCOLOGY

Patients With Malignancy Requiring Urgent Therapy

CASE 2. Bilateral Renal Swelling Induced by Adult T-Cell Leukemia/Lymphoma

Taiji Yokote, Toshikazu Akioka, Satoshi Hara, Satoko Oka, Hiroyuki Miyamoto, Takeshi Yamano, Masakazu Sugino, Motomu Tsuji, Toshiaki Hanafusa

First Department of Internal Medicine, and Division of Surgical Pathology, Osaka Medical College, Takatsuki City, Osaka, Japan

A 55-year-old Japanese man was admitted to our hospital with confusion and hypouresis. Physical examination showed bilateral renal swelling (Fig 1). Serum calcium and creatinine levels were 4.58 mmol/L and 497.6 µmol/L, respectively. His plasma parathyroid hormone (PTH) –related protein (PTHrP) level was elevated to 4.2 pmol/L (normal, < 0.6 pmol/L), and intact PTH was suppressed to 6 pg/mL (normal range, 10 to 65 pg/mL). A serologic test for antihuman T-cell leukemia virus type-1 antibody was positive, and bone marrow biopsy demonstrated diffuse infiltration of abnormal T lymphocytes, characterized by an irregular nuclear contour and variably prominent nucleoli. Consequently, adult T-cell leukemia/lymphoma (ATLL) was diagnosed. Immunohistochemical staining of the bone marrow biopsy showed the abnormal lymphocytes to be positive for PTHrP antibodies (Fig 2). An open renal biopsy demonstrated relatively normal glomerulus; however there was calcification, degeneration, and destruction of the tubular epithelium (Fig 3). Unfortunately, 2 days later, the patient died suddenly from cardiac arrhythmia.



View larger version (83K):
[in this window]
[in a new window]
 
Fig 1.
 


View larger version (133K):
[in this window]
[in a new window]
 
Fig 2.
 


View larger version (131K):
[in this window]
[in a new window]
 
Fig 3.
 
Hypercalcemia is a serious and frequent complication of malignant disease, occurring in 10% to 20% of patients with malignancies. As many as 80% of hypercalcemias are due to humoral hypercalcemia of malignancy.1 Hypercalcemia is a common finding in patients with ATLL. Elevated levels of serum PTHrP have been detected in hypercalcemic patients with ATLL.2 ATLL cells express PTHrP mRNA and secrete PTHrP into culture medium.3 Therefore, PTHrP is considered to be one of the primary causes of humoral hypercalcemia of malignancy with ATLL.

Hypercalcemia induces variable degrees of renal impairment, as has been shown by milk-alkali syndrome, and the pathophysiology of this syndrome is complex.4 In milk-alkali syndrome, calcium deposition is not usually evident on radiologic examination. Furthermore, there have been very few reports of these findings with renal biopsy. Histologic examination demonstrates hyalinization of the glomeruli, degeneration of the tubular epithelium, calcium deposition, and inflammatory reactive changes.5 Although renal infiltration in ATLL has been previously reported,6 to our knowledge to date, the present article is the first reported case of renal failure due to hypercalcemia in which biopsy has been performed. Hypercalcemia may induce renal failure, and physicians should be cognizant of this complication when elevated levels of serum PTHrP are detected in hypercalcemic patients with malignancy.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Yen Y, Chu PG, Feng W: Paraneoplastic syndromes in cancer: Case 3—Parathyroid hormone–related hypercalcemia in cholangiocarcinoma. J Clin Oncol 22:2244-2245, 2004[Free Full Text]

2. Motokura T, Fukumoto S, Takahashi S, et al: Expression of parathyroid hormone-related protein in a human T cell lymphotrophic virus type I-infected T cell line. Biochem Biophys Res Commun 154:1182-1188, 1988[Medline]

3. Ikeda K, Ohno H, Hane M, et al: Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: Evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma. J Clin Endocrinol Metab 79:1322-1327, 1994[Abstract]

4. Orwoll ES: The milk-alkali syndrome: Current concepts. Ann Intern Med 97:242-248, 1982

5. Junor BJ, Catto GR: Renal biopsy in the milk-alkali syndrome. J Clin Pathol 29:1074-1076, 1976[Abstract/Free Full Text]

6. Srinivasa NS, McGovern CH, Solez K, et al: Progressive renal failure due to renal invasion and parenchymal destruction by adult T-cell lymphoma. Am J Kidney Dis 16:70-72, 1990[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokote, T.
Right arrow Articles by Hanafusa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokote, T.
Right arrow Articles by Hanafusa, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online